Commentary - (2025) Volume 10, Issue 5
Received: 01-Oct-2025, Manuscript No. jidm-26-188102;
Editor assigned: 04-Oct-2025, Pre QC No. P-188102;
Reviewed: 18-Oct-2025, QC No. Q-188102;
Revised: 22-Oct-2025, Manuscript No. R-188102;
Published:
29-Oct-2025
, DOI: 10.37421/2576-1420.2025.10.429
Citation: Chaiyaporn, Somchai. ”Global and Thai STIs: Landscape,
Challenges, and Control.” J Infect Dis Med 10 (2025):429.
Copyright: © 2025 Chaiyaporn S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
The global epidemiological landscape of sexually transmitted infections (STIs) presents a persistent and complex challenge, demanding continuous surveillance and targeted interventions to mitigate their substantial public health burden. These infections, encompassing a wide range of bacterial, viral, and parasitic agents, continue to affect millions worldwide, contributing to significant morbidity and mortality, as well as socioeconomic costs. Understanding the nuanced patterns of prevalence, incidence, and transmission is crucial for developing effective control strategies and improving health outcomes across diverse populations and geographical regions [1].
In the specific context of Southeast Asia, the co-infection of Human Immunodeficiency Virus (HIV) and syphilis emerges as a particularly grave public health concern. This overlapping epidemic necessitates a comprehensive understanding of regional epidemiological trends, prevalent risk behaviors, and the efficacy of current prevention and treatment modalities. The findings from such analyses are instrumental in advocating for integrated sexual health and HIV services, which are vital for reducing transmission rates and enhancing patient outcomes within the region [2].
The escalating threat of antimicrobial resistance (AMR) in key bacterial STIs, such as Neisseria gonorrhoeae, poses a formidable challenge to public health initiatives. In Thailand, the emergence of resistance to commonly used antibiotics in gonorrhea strains necessitates an in-depth investigation into resistance patterns and the contributing factors. This research is critical for informing treatment guidelines and underscoring the urgent need for enhanced surveillance and the development of novel therapeutic options to combat this growing menace [3].
Genital herpes simplex virus (HSV) infections, particularly HSV-2, represent a significant and often chronic STI affecting young adults in urban settings like Thailand. Characterizing the epidemiological features, including prevalence and associated sexual risk factors, is essential for understanding the clinical impact and for developing targeted public health interventions. Emphasizing comprehensive sexual health education and accessible testing and counseling services remains paramount in addressing this widespread infection [4].
Human papillomavirus (HPV) infection and its sequelae, including various cancers, represent another substantial public health burden in Thailand. An epidemiological overview that includes vaccination coverage and the projected impact of immunization programs on disease incidence is vital. Addressing the challenges in achieving high vaccination rates and sustaining public health efforts are key to its control [5].
The resurgence of chancroid in Thailand highlights the dynamic and sometimes cyclical nature of certain STIs, emphasizing the importance of ongoing epidemiological surveillance. Understanding the current patterns of incidence, geographical distribution, and the role of mobile populations in transmission is critical for developing targeted interventions aimed at controlling this often-neglected infection and its associated public health implications [6].
Trichomoniasis, a common curable STI, presents its own set of epidemiological challenges in Thailand. Examining its prevalence, associated symptoms, and risk factors is important, especially in light of the diagnostic and management difficulties often encountered in resource-limited settings. Increased awareness and proactive screening initiatives are vital for effectively addressing this infection [7].
The increasing recognition of Mycoplasma genitalium as an emerging STI in Thailand necessitates a deeper understanding of its epidemiological landscape. Current knowledge regarding its prevalence, clinical presentations, and diagnostic complexities is still evolving. Greater research attention and public health focus are urgently required to address this frequently underdiagnosed infection and its potential health consequences [8].
Bacterial vaginosis (BV) in women in Thailand is not only a common condition but also shows significant associations with other STIs, including HIV and HPV. Examining its prevalence, risk factors, and its impact on susceptibility to other infections is crucial. This understanding underscores the need for integrated screening and management approaches to address the complex interplay of these conditions [9].
Finally, the investigation of novel STI outbreaks, such as the one recently observed in Thailand, is paramount for public health preparedness. Analyzing transmission routes, clinical manifestations, and the effectiveness of public health response strategies provides critical insights for future preparedness and rapid response mechanisms to emerging infectious diseases and their epidemiological impact [10].
The global epidemiological tapestry of sexually transmitted infections (STIs) is characterized by enduring challenges that necessitate ongoing vigilance and strategic interventions to curtail their significant impact on public health worldwide. These pervasive infections, caused by a diverse array of microbial agents including bacteria, viruses, and parasites, continue to afflict millions, contributing to substantial morbidity, mortality, and considerable economic burdens. A thorough comprehension of the intricate patterns governing their prevalence, incidence, and modes of transmission is indispensable for the formulation of efficacious control measures and the enhancement of health outcomes across varied populations and geographic locales [1].
Within the specific purview of Southeast Asia, the alarming confluence of Human Immunodeficiency Virus (HIV) and syphilis co-infection emerges as a particularly acute public health crisis. This intertwined epidemic demands a nuanced understanding of regional epidemiological trajectories, prevailing behavioral risk factors, and the demonstrated effectiveness of contemporary prevention and therapeutic strategies. The insights gleaned from such analytical endeavors are fundamental to advocating for and implementing integrated sexual health and HIV services, which are indispensable for curtailing transmission rates and improving patient prognoses throughout the region [2].
The escalating specter of antimicrobial resistance (AMR) in critical bacterial STIs, most notably Neisseria gonorrhoeae, presents a formidable obstacle to global public health endeavors. In Thailand, the burgeoning resistance observed in gonorrhea strains against widely utilized antibiotics mandates a meticulous examination of resistance profiles and the underlying contributing elements. Such research is pivotal for informing the development and revision of treatment protocols and for underscoring the imperative need for augmented surveillance and the innovation of novel therapeutic agents to combat this intensifying threat [3].
Genital herpes simplex virus (HSV) infections, with a particular emphasis on HSV-2, constitute a substantial and often chronic STI that disproportionately affects young adults in urban centers such as Thailand. A detailed characterization of its epidemiological attributes, encompassing prevalence rates and associated sexual risk determinants, is vital for appreciating its clinical ramifications and for designing tailored public health interventions. The unwavering emphasis on comprehensive sexual health education and the provision of accessible diagnostic and counseling services remains of paramount importance in managing this widespread infection [4].
Human papillomavirus (HPV) infection and its associated malignant sequelae represent another significant public health burden within Thailand. An epidemiological overview that meticulously documents vaccination coverage rates and forecasts the potential impact of immunization initiatives on disease incidence is of critical importance. Addressing the existing impediments to achieving high vaccination uptake and sustaining robust public health efforts are key determinants in its successful control [5].
The observable resurgence of chancroid in Thailand underscores the dynamic and often cyclical nature of specific STIs, thereby highlighting the indispensable role of continuous epidemiological monitoring. A thorough grasp of current incidence patterns, geographic distribution, and the role played by transient or mobile populations in transmission dynamics is essential for the development of precise interventions aimed at controlling this frequently overlooked infection and its broader public health implications [6].
Trichomoniasis, a prevalent and treatable STI, presents its own unique epidemiological challenges within Thailand. A systematic examination of its prevalence, associated symptomatology, and identified risk factors is crucial, especially given the diagnostic and management complexities often encountered in environments with limited resources. Amplified public awareness and proactive screening programs are indispensable for the effective containment of this infection [7].
The burgeoning recognition of Mycoplasma genitalium as an emergent STI in Thailand mandates a more profound comprehension of its epidemiological characteristics. Current understanding concerning its prevalence, clinical manifestations, and diagnostic intricacies is still undergoing development. There is an urgent need for increased research endeavors and focused public health attention to adequately address this frequently underdiagnosed infection and its potential health consequences [8].
Bacterial vaginosis (BV), prevalent among women in Thailand, exhibits significant correlations with other STIs, including HIV and HPV. An investigation into its prevalence rates, contributing risk factors, and its influence on susceptibility to other infections is of considerable importance. This foundational knowledge emphasizes the critical need for the implementation of integrated screening and management strategies to effectively address the complex interplay of these conditions [9].
Lastly, the meticulous investigation of novel STI outbreaks, exemplified by the recent occurrence in Thailand, is of utmost importance for ensuring robust public health preparedness. A thorough analysis of transmission pathways, clinical presentations, and the efficacy of implemented public health response strategies provides invaluable intelligence for future preparedness and swift reaction mechanisms to emerging infectious diseases and their attendant epidemiological ramifications [10].
This collection of research highlights the multifaceted epidemiological landscape of sexually transmitted infections (STIs) globally and specifically within Thailand. Common STIs like chlamydia, gonorrhea, syphilis, and HIV remain a significant burden, with variations in demographic trends, risk factors, and geographical distribution. Challenges in STI control include diagnostic limitations, treatment resistance, especially for gonorrhea, and barriers to healthcare access. Emerging STIs such as Mycoplasma genitalium and the resurgence of chancroid are also noted. Specific regional concerns include HIV and syphilis co-infection in Southeast Asia. The impact of HPV and genital herpes on young adults is discussed, along with the management of bacterial vaginosis and its association with other STIs. The importance of surveillance, targeted interventions, comprehensive sexual health education, and rapid response to novel outbreaks is emphasized throughout these studies.
Journal of Infectious Diseases and Medicine received 1059 citations as per Google Scholar report
